Category: Contract Pharmacy Protection Bills

In Novel Approach, Vertex to Automatically Exempt States from 340B Contract Pharmacy Restrictions as New Laws Take Effect and Apply Exemptions Liberally; Other Companies Exempt Additional States

May 8, 2025 Bella Czajkowski, National Correspondent Views

Multiple drugmakers announced exemptions to contract pharmacy restrictions recently, including Vertex, which will automatically exempt states that enact contract pharmacy access laws moving forward.

Four drugmakers recently announced they will exempt additional states from their 340B contract pharmacy restrictions in response to a flurry [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Contract Pharmacy Lawsuit Roundup: Key Briefs Filed in Nebraska, South Dakota and 5th Circuit

May 8, 2025 Bella Czajkowski, National Correspondent Views

Key briefs were filed recently in Nebraska, South Dakota and the 5th Circuit.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Sumitomo Exempts Four More States From 340B Contract Pharmacy Restrictions, GSK Exempts Nebraska, Utah

May 1, 2025 Shannon Young, Associate Editor/Senior Writer Views

Sumitomo Pharma America has announced exemptions to its contract pharmacy restrictions for 340B covered entities in Nebraska, North Dakota, South Dakota and Utah.

Two major drug manufacturers are loosening their 340B contract pharmacy restrictions for states that have passed contract pharmacy access laws [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

State Contract Pharmacy Lawsuit Roundup: 5th Circuit Appeals in Louisiana, 4th Circuit Appeal in West Virginia

April 17, 2025 Shannon Young and Bella Czajkowski, Associate Editor/Senior Writer Views

Key briefs were filed recently in state contract pharmacy litigation in West Virginia and Louisiana.

Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Merck is First to Exempt South Dakota from 340B Contract Pharmacy Restrictions but Reinstates in Kansas, Novartis Exempts Missouri

March 25, 2025 Bella Czajkowski, National Correspondent Views

Merck announced it will exempt South Dakota from its contract pharmacy restrictions and reinstate them in Kansas. Novartis will exempt Missouri from its contract pharmacy restrictions.

Drugmakers Merck and Novartis recently updated their 340B contract pharmacy restrictions, modifying what states are exempt from such policies following [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Advocate Slams Federal ‘No 340B Savings for Transgender Care Act’ Proposal

March 20, 2025 Shannon Young, Associate Editor/Senior Writer Views

Peggy Tighe, a principal at Powers Law, told 340B Report that U.S. Rep. Dusty Johnson’s (R-S.D.) bill "appears to be an attempt to thwart attacks against the 340B program, perhaps to protect GOP state and federal legislators, but it is anti-states' rights and an overreaction to a false and incendiary campaign.”

A 340B program advocate this week condemned a new GOP U.S. House bill that would prohibit covered entities from using [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

340B Misinformation Makes Up Small Part of 340B Conversations Online, But Garners Outsized Attention, Analysis Finds

March 11, 2025 Shannon Young, Associate Editor/Senior Writer Views

Storyful Rx analyzed more than 6,000 social media posts and articles mentioning the 340B program between Aug. 11, 2024 and Feb. 11, 2025.

Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Recap of Recent Webinar: A Closer Look at Battles Over State 340B Contract Pharmacy Access Bills and Laws

March 11, 2025 Bella Czajkowski, National Correspondent Views

340B Report's latest webinar overviewed contract pharmacy developments in state legislatures and the courts, plus how a dark money group has ramped up anti-340B ads.

As state legislatures ramp up efforts to protect contract pharmacy access, drug industry lawsuits against existing state laws continue to [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Dark Money Group Labels Five GOP State Lawmakers As ‘Trump Underminers,’ But Efforts Appear to be Backfiring

March 6, 2025 Shannon Young, Associate Editor/Senior Writer Views

Building America’s Future targeted five GOP state lawmakers backing contract pharmacy access bills in a new ad.

A Washington D.C. dark money group with White House ties recently upped its attacks on 340B contract pharmacy access bills [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Dark-Money 340B Attacks, Rebate Model Among Key Concerns at 340B Coalition Winter Conference

February 25, 2025 Shannon Young, Associate Editor/Senior Writer Views

340B Health leader Maureen Testoni criticizes a dark-money group's misleading ads during her talk at the 2025 340B Coalition Winter Conference in San Diego.

Concerns over a highly charged and misleading dark-money campaign targeting state contract pharmacy access bills and the legal fight surrounding [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a

…

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Please Login or Become a Paid Subscriber to View this Content

If you are already a

News Alert

Please Login or Become a Paid Subscriber to View this Content

If you are already a

Site Footer Live